You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SARS-CoV-2 spike

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Infection Trial in Germany, United States (PRIME-2-CoV_Beta)

Recruiting
  • SARS-CoV-2 Infection
  • Florida City, Florida
  • +6 more
Jan 31, 2023

Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )

Completed
  • Covid19
  • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
  • Saline placebo
  • Tehran, Iran, Islamic Republic of
    Espinas Palace Hotel
Oct 11, 2022

Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )

Completed
  • Covid19
  • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
  • Saline placebo
  • Tehran, Iran, Islamic Republic of
    Espinas Palace Hotel
Oct 11, 2022

SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

Recruiting
  • SARS-CoV-2 Infection
  • B/HPIV3/S-6P
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Aug 30, 2023

COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

Suspended
  • COVID-19 Infection
  • +2 more
  • Questionnaire Administration
  • Sotrovimab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 24, 2023

Covid19 Trial in Lenexa, Raleigh (Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal

Recruiting
  • Covid19
  • Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops
  • +4 more
  • Lenexa, Kansas
  • +1 more
Aug 1, 2022

COVID-19 Trial in Vienna (Immunosuppression reduction, No immunosuppression reduction)

Active, not recruiting
  • COVID-19
  • Immunosuppression reduction
  • No immunosuppression reduction
  • Vienna, Austria
    Medical University of Vienna
Apr 16, 2022

SARS-CoV2 Infection Trial in Renton (HDT-301)

Active, not recruiting
  • SARS-CoV2 Infection
  • HDT-301
  • Renton, Washington
    Rainier Clinical Research
Jan 16, 2023

Covid19 Trial in United States (CVXGA1 low dose, CVXGA1 high dose)

Recruiting
  • Covid19
  • CVXGA1 low dose
  • CVXGA1 high dose
  • Bardstown, Kentucky
  • +3 more
Aug 16, 2022

COVID-19 Trial in Kunming (ZR-202-CoV, Placebo)

Recruiting
  • COVID-19
  • ZR-202-CoV
  • Placebo
  • Kunming, Yunan, China
    Clinical Trial Institution for Anning First Hospital
Apr 5, 2022

Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines Trial in Chongqing (drug, diagnostic test,

Completed
  • Severe Acute Respiratory Syndrome-related Coronavirus
  • +4 more
  • Nifedipine 30 MG
  • +10 more
  • Chongqing, Chongqing, China
    Residential Address
Feb 1, 2023

COVID-19 Trial in Petach Tikva (no intervantion)

Active, not recruiting
  • COVID-19
  • no intervantion
  • Petach Tikva, Israel
    Schneider Children's Medical Center
Sep 29, 2022

COVID-19 Trial in United Kingdom (Sotrovimab)

Recruiting
  • COVID-19
  • Cardiff, United Kingdom
  • +3 more
Jul 25, 2022

COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)

Active, not recruiting
  • COVID-19
  • Vienna, Austria
    Medicial University of Vienna
Apr 12, 2022

Profiling Spike Protein Antibody Response Post COVID Booster

Not yet recruiting
  • SARS-CoV-2 Booster
  • Spike Protein IgG Antibody
  • Obtain antibody titers
  • (no location specified)
Jul 25, 2022

Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients

Completed
  • SARS-CoV-2 Vaccination
  • Liver Transplantation
  • Immunoassay, by ECLIA, for the quantitative in vitro determination of antibodies (including IgG) to the SARS - CoV - 2 spike protein (S) anti-RBD (receptor-binding domain) in serum and plasma samples.
  • Roma, Italy
    Policlinico Tor Vergata
Aug 3, 2022

Healthy, Chronic Stable Illness Trial in Miami, Winter Park (Casirivimab+Imdevimab)

Completed
  • Healthy
  • Chronic Stable Illness
  • Miami, Florida
  • +1 more
Jun 15, 2022

SARS-CoV-2 Infection Trial in Silver Spring (25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant), Sodium chloride, USP, for injection

Active, not recruiting
  • SARS-CoV-2 Infection
  • 25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)
  • +2 more
  • Silver Spring, Maryland
    WRAIR Clinical Trials Center
Sep 13, 2021

COVID-19 Trial in Xuchang (202-CoV low adjuvant dose, 202-CoV low antigen dose, 202-CoV standard dose)

Recruiting
  • COVID-19
  • 202-CoV low adjuvant dose
  • +3 more
  • Xuchang, China
    Xiangcheng Center for Disease Control and Prevention
Aug 2, 2021

COVID-19 Trial in Stony Brook, Memphis (casirivimab+imdevimab)

Terminated
  • COVID-19
  • Stony Brook, New York
  • +1 more
Jul 26, 2022

COVID-19 Trial in Xuchang (202-CoV low adjuvant dose, 202-CoV low antigen dose, 202-CoV standard dose)

Recruiting
  • COVID-19
  • 202-CoV low adjuvant dose
  • +3 more
  • Xuchang, China
    Xiangcheng Center for Disease Control and Prevention
Jul 29, 2021

Sarcoidosis, SARS-CoV2 Infection, Vaccine Response Impaired Trial in Chicago (Assay of (1) the level of anti-spike IgG antibody,

Recruiting
  • Sarcoidosis
  • +2 more
  • Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation
  • Chicago, Illinois
    Northwestern Medicine
Dec 6, 2021

Covid19 Trial in Maputo (BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell), Ad26.COV2.S (Recombinant,

Recruiting
  • Covid19
  • BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell)
  • +2 more
  • Maputo, Mozambique
    Centro de Investigação e Treino em Saúde da Polana Caniço - Inst
Mar 31, 2022

Covid19 Trial in Ankara, Istanbul, Kocaeli (SARS-CoV-2 VLP Vaccine-Wuhan, SARS-CoV-2 VLP Vaccine-Alpha (British) variant,

Completed
  • Covid19
  • SARS-CoV-2 VLP Vaccine-Wuhan
  • +2 more
  • Ankara, Turkey
  • +2 more
May 24, 2022

COVID-19 Trial in Tehran (Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, SARS-CoV-2 recombinant spike

Completed
  • COVID-19
  • Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
  • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
  • Tehran, Iran, Islamic Republic of
    Orchid Life Department, Orchid Pharmed Company
Oct 13, 2022